These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35086669)
21. Relationship of carbon monoxide pulmonary diffusing capacity to postoperative cardiopulmonary complications in patients undergoing pneumonectomy. Wang JS Kaohsiung J Med Sci; 2003 Sep; 19(9):437-46. PubMed ID: 14604318 [TBL] [Abstract][Full Text] [Related]
22. Prediction formula for predicted diffusion capacity of lung for carbon monoxide in pulmonary surgery. Kanno H; Deguchi H; Tomoyasu M; Kudo S; Shigeeda W; Kaneko Y; Yoshimura R; Saito H Gen Thorac Cardiovasc Surg; 2020 Dec; 68(12):1432-1438. PubMed ID: 32623560 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer. Goense L; Meziani J; Bülbül M; Braithwaite SA; van Hillegersberg R; Ruurda JP Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30239639 [TBL] [Abstract][Full Text] [Related]
24. Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension? Delcour KS; Singla A; Jarbou M; Alpert M; Dabbagh O Am J Med Sci; 2010 Jul; 340(1):54-9. PubMed ID: 20463574 [TBL] [Abstract][Full Text] [Related]
25. Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life. Liu M; Wampfler JA; Dai J; Gupta R; Xue Z; Stoddard SM; Cassivi SD; Jiang G; Yang P Lung Cancer; 2017 Apr; 106():37-41. PubMed ID: 28285692 [TBL] [Abstract][Full Text] [Related]
26. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%. Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005 [TBL] [Abstract][Full Text] [Related]
27. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC). Almquist D; Khanal N; Smith L; Ganti AK Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115 [TBL] [Abstract][Full Text] [Related]
28. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Beckles MA; Spiro SG; Colice GL; Rudd RM; Chest; 2003 Jan; 123(1 Suppl):105S-114S. PubMed ID: 12527570 [TBL] [Abstract][Full Text] [Related]
29. Diffusing Capacity of Carbon Monoxide in Assessment of COPD. Balasubramanian A; MacIntyre NR; Henderson RJ; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Make BJ; Wise RA; McCormack MC Chest; 2019 Dec; 156(6):1111-1119. PubMed ID: 31352035 [TBL] [Abstract][Full Text] [Related]
30. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection. Axtell AL; David EA; Block MI; Parsons N; Habib R; Muniappan A Ann Thorac Surg; 2023 Sep; 116(3):533-541. PubMed ID: 37271447 [TBL] [Abstract][Full Text] [Related]
31. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Gopal R; Starkschall G; Tucker SL; Cox JD; Liao Z; Hanus M; Kelly JF; Stevens CW; Komaki R Int J Radiat Oncol Biol Phys; 2003 May; 56(1):114-20. PubMed ID: 12694829 [TBL] [Abstract][Full Text] [Related]
32. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. van der Lee I; Zanen P; Grutters JC; Snijder RJ; van den Bosch JMM Chest; 2006 Feb; 129(2):378-383. PubMed ID: 16478855 [TBL] [Abstract][Full Text] [Related]
33. Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis. Suda R; Tanabe N; Ishida K; Kato F; Urushibara T; Sekine A; Nishimura R; Jujo T; Sugiura T; Shigeta A; Sakao S; Tatsumi K Respirology; 2017 Jan; 22(1):179-186. PubMed ID: 27614712 [TBL] [Abstract][Full Text] [Related]
34. Effects of Smoking, Obesity, and Pulmonary Function on Home Oxygen Use after Curative Lung Cancer Surgery. Nicastri DG; Chan H; You N; Yip R; Ray K; Taioli E; Yankelevitz DF; Henschke CI; Flores RM; Ann Am Thorac Soc; 2022 Mar; 19(3):442-450. PubMed ID: 34699344 [No Abstract] [Full Text] [Related]
35. Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer. Grambozov B; Wolf F; Kaiser J; Wass R; Fastner G; Gaisberger C; Rettenbacher L; Studnicka M; Pirich C; Sedlmayer F; Zehentmayr F Thorac Cancer; 2020 Feb; 11(2):369-378. PubMed ID: 31855325 [TBL] [Abstract][Full Text] [Related]
36. Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer. Kreuter M; Vansteenkiste J; Herth FJ; Fischer JR; Eberhardt W; Zuna I; Reinmuth N; Griesinger F; Thomas M; Respiration; 2014; 87(3):204-10. PubMed ID: 24192055 [TBL] [Abstract][Full Text] [Related]
37. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Ferguson MK; Watson S; Johnson E; Vigneswaran WT Eur J Cardiothorac Surg; 2014 Apr; 45(4):660-4. PubMed ID: 24052607 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of pulmonary diffusing capacity for carbon monoxide and ventilation-perfusion SPECT findings in pulmonary arterial hypertension. Mohammad M; Hartmann JP; Carlsen J; Greve AM; Berg RMG; Mortensen J Exp Physiol; 2024 Jul; 109(7):1040-1050. PubMed ID: 38725160 [TBL] [Abstract][Full Text] [Related]
39. Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancer. Macke RA; Schuchert MJ; Odell DD; Wilson DO; Luketich JD; Landreneau RJ J Cardiothorac Surg; 2015 Apr; 10():49. PubMed ID: 25888465 [TBL] [Abstract][Full Text] [Related]